Nom du produit:2,5-difluoro-4-(trifluoromethyl)benzaldehyde
IUPAC Name:2,5-difluoro-4-(trifluoromethyl)benzaldehyde
- CAS:134099-33-5
- Formule moléculaire:C8H3F5O
- Pureté:95%+
- Numéro de catalogue:CM458962
- Poids moléculaire:210.1
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:134099-33-5
- Formule moléculaire:C8H3F5O
- Point de fusion:-
- Code SMILES:FC1=CC(C=O)=C(F)C=C1C(F)(F)F
- Densité:
- Numéro de catalogue:CM458962
- Poids moléculaire:210.1
- Point d'ébullition:
- N° Mdl:MFCD28714769
- Stockage:
Column Infos
- Nelutroctiv
- The Journal of Medicinal Chemistry recently publishes an article titled, “Discovery of Nelutroctiv (CK-136), a Selective Cardiac Troponin Activator for the Treatment of Cardiovascular Diseases Associated with Reduced Cardiac Contractility”. Heart failure (HF) is a lifelong clinical syndrome and remains a major societal concern. Cardiac myosin activators constitute a new class of inotropes and are found to be a viable therapeutic approach for increasing myocardial contractility.
CK-136 is a small molecule cardiac troponin activator that is discovered under a previous joint research program between Cytokinetics and Amgen. It acts on the sarcomere and is designed to improve myocardial contractility by sensitizing cardiac troponin to calcium, increasing actin-myosin cross bridge formation during each cardiac cycle. CK-136 is developed as a potential treatment for heart failure (HF) with reduced ejection fraction (HFrEF) and other types of heart failure, and currently under phase 1 clinical investigation.